KOD - Company ID 0001468748
The table below shows Kodiak Sciences Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$136.01M | -$117.32M | -$154.18M | -$206.46M | -$182.27M | -$83.43M |
| Capital expenditure | $506.00K | $375.00K | $41.35M | $37.02M | $17.03M | $3.81M |
| Investing cash flow | -$506.00K | -$755.00K | $249.23M | -$336.51M | -$38.80M | $104.83M |
| Dividends paid | - | - | - | - |
Kodiak Sciences Inc. reported operating cash flow of -$136.01M for fiscal year 2025. That is down 15.9% from -$117.32M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$16.05M (FY 2016) to -$136.01M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $178.30M | $501.00K | $31.00K | $1.90M | $8.18M | $717.38M |